NeurologyLive® Year in Review 2024: Most-Read Features

Throughout the course of the year, the NeurologyLive^® team and a number of clinician and physician partners put together feature-length, in-depth articles that encapsulate the topics and themes that have driven the conversations in the field of neurology in 2024.

From a review of the ongoing shortage of physicians to an overview of the achievements that the field has experienced, these stories offer insight from a variety of experts in neurology. Featuring commentary and perspectives from those involved in clinical care, advocacy, and industry, these pieces were crafted to provide a deeper look into some of the ongoing discussions, problems, and controversies that have, in part, dominated this year. These pieces were authored not only by staff members of NeurologyLive^® but physicians who experience these discussions first-hand.

Here, we'll highlight the most-read features on NeurologyLive^® this year. Click the buttons to read further into these conversations.

1. Widen the Window, Close the Gap: Revolutionizing Stroke Care in Alaska

A partnership between a stroke expert coalition and the technology offered by RapidAI has provided a potential roadmap for improving rural stroke care in remote areas of the United States.

2. Building the Archetype for MOGAD Care: Introducing Mayo’s New Clinic

Mayo's MOGAD Clinic represents a new type of novel, multidisciplinary care, incorporating multiple different backgrounds of neurology, neuroimmunology, neuro—ophthalmology, and urology, among others.

3. Treating NMOSD: Where Do We Go After Complement Inhibition's Success?

Newly approved treatments in neuromyelitis optica spectrum disorder have shown efficacy in recent years, yet unaddressed concerns voiced by clinicians and patients living with the disease remain.

4. What Progress Have We Made in Mitigating Racial Disparities in Stroke?

Experts in stroke care express a need for significant increases in awareness of stroke risk factors and symptoms in patient communities that experience racial disparities.

5. Understanding the Significant Role of Secondary Symptoms of Parkinson Disease

Parkinson disease (PD), a progressive neurodegenerative disorder involving multiple neurotransmitter pathways in the brain and autonomic nervous system, has been typically characterized by motor symptoms including tremor, bradykinesia, rigidity, and postural reflex disturbance. Although these dopaminergic motor symptoms are a major part of the clinical management of the disease, a growing number of patients have expressed that the nonmotor, secondary symptoms affect their quality of life even more.

6. Cerebroprotection As An Approach for Ischemic Stroke Care

The conversations behind cerebroprotection in stroke have begun to get louder, with a pipeline that includes several different approaches to treatment.

7. Raising the Standard for Stroke Care and Education: Cleveland Clinic’s Minority Stroke Program

The Minority Stroke Program, open since 2019, encompasses a group of highly trained stroke experts who provide high quality care and education for minority ethnic patients presenting with stroke.

8. Where Are We: Development of Gene and Cell Approaches for Parkinson Disease

According to recent studies and the latest insights provided by experts, early developments in gene and cell therapies show promise for patients living with Parkinson disease, but challenges remain.

9. Benefitting From Bicultural Communication: Cleveland Clinic's Hispanic Sleep Disorders Center

Latino adults in the US experience high rates of sleep disorders, with cultural and language barriers exacerbating healthcare challenges. Cleveland Clinic's new sleep disorders clinic offers bilingual services to improve care for Hispanic patients, addressing cultural and language barriers.

10. System Integration: How AI Is Weaving Itself into Neurology

Artificial intelligence (AI) refers to the use of computer systems or machines to simulate human intelligence processes such as learning, reasoning, problem-solving, and decision-making. This feature comprises perspective from neurologists on the current and future applications for artificial intelligence across a bevy of neurologic conditions.